Infliximab is a plausible alternative for neurologic complications of Behçet disease

OBJECTIVE: We evaluated the effectiveness of infliximab in patients with neuro-Behçet syndrome for whom other immunosuppressive medications had failed. METHODS: Patients whose common immunosuppressive medications fail in recurrent neuro-Behçet syndrome need an alternative. We report our experience w...

Descripción completa

Detalles Bibliográficos
Autores principales: Zeydan, Burcu, Uygunoglu, Ugur, Saip, Sabahattin, Demirci, Onat N., Seyahi, Emire, Ugurlu, Serdal, Hamuryudan, Vedat, Siva, Aksel, Kantarci, Orhun H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2016
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4950829/
https://www.ncbi.nlm.nih.gov/pubmed/27458602
http://dx.doi.org/10.1212/NXI.0000000000000258

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4950829/
https://www.ncbi.nlm.nih.gov/pubmed/27458602
http://dx.doi.org/10.1212/NXI.0000000000000258

Ejemplares similares